Overview

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

Status:
Recruiting
Trial end date:
2022-02-16
Target enrollment:
Participant gender:
Summary
To determine an effective dose of VERU-100 for the treatment of advanced prostate cancer by assessing its effect on testosterone levels by Day 28 and maintenance through Day 91.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Veru Inc.
Treatments:
Cetrorelix